AR and prostate carcinoma: ER and AR, ligand-dependent transcription factors, are activated by sex hormones and responsible for the regulation of cell proliferation, survival and differentiation (Shafi et al., 2013; Berkel and Cacan, 2021) in breast (Anestis et al., 2020) and prostate cancer (Tan et al., 2015), respectively.